Compare two aspirin doses after blunt vessel injury
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking a lower-dose aspirin (81 mg) works as well as a higher-dose aspirin (325 mg) to prevent stroke after a blunt injury that affects blood vessels in the neck/head. It may help some patients lower their stroke risk with the simplest, safest dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- Your injury was found as blunt cerebrovascular injury using a CTA scan
- You are not pregnant
- You can take aspirin through a feeding tube or other enteral route
- You are not already on a heparin drip or full-dose blood thinner
- You are not taking another anti-platelet medicine besides aspirin
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a low dose of aspirin soon after a stroke, when clot-busting medication has already been given, is safe and helps improve recovery. It may help prevent another stroke and is designed for people whose strokes are caused by blocked blood vessels in the brain.
This study compares two ways to treat a minor stroke: taking two blood-thinning pills (aspirin and clopidogrel) versus receiving a clot-busting medicine (alteplase) through an IV. The goal is to see which approach works better and has fewer side effects.
This study tests whether adjusting blood-thinner medication based on a blood test can better prevent another stroke in people who recently had a minor stroke or a high-risk mini-stroke. It aims to find the safest and most effective dose for each patient.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
Hear when a new Blunt Cerebrovascular Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.